Evidence map›Paper›PMID 35163433›Full record

ArticleInternational journal of molecular sciences2022

Nonsteroidal Anti-Inflammatory Drugs as PPARγ Agonists Can Induce PRODH/POX-Dependent Apoptosis in Breast Cancer Cells: New Alternative Pathway in NSAID-Induced Apoptosis.

Adam Kazberuk, Magda Chalecka, Jerzy Palka, Arkadiusz Surazynski

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Nuclear Receptors in Health and Diseases.International journal of molecular sciences · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Adam KazberukDepartment of Medicinal Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-8485-6505
Magda ChaleckaDepartment of Medicinal Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-0225-9740
Jerzy PalkaDepartment of Medicinal Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-8476-2023
Arkadiusz SurazynskiDepartment of Medicinal Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0003-4475-873X
Medical University of Białystok · PL

Funding

National Science Centre 2017/27/N/NZ7/02370
6 · The paper itself

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered to be therapeutics in cancer prevention because of their inhibitory effect on cyclooxygenases (COX), which are frequently overexpressed in many types of cancer. However, it was also demonstrated that NSAIDs provoked a proapoptotic effect in COX knocked-out cancer cells. Here, we suggest that this group of drugs may provoke antineoplastic activity through the activation of PPARγ, which induces proline dehydrogenase/proline oxidase (PRODH/POX)-dependent apoptosis. PRODH/POX is a mitochondrial enzyme that catalyzes proline degradation, during which ATP or reactive oxygen species (ROS) are generated. We have found that NSAIDs induced PRODH/POX and PPARγ expressions (as demonstrated by Western Blot or immunofluorescence analysis) and cytotoxicity (as demonstrated by MTT, cytometric assay, and DNA biosynthesis assay) in breast cancer MCF7 cells. Simultaneously, the NSAIDs inhibited collagen biosynthesis, supporting proline for PRODH/POX-induced ROS-dependent apoptosis (as demonstrated by an increase in the expression of apoptosis markers). The data suggest that targeting proline metabolism and the PRODH/POX-PPARγ axis can be considered a novel approach for breast cancer treatment.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsApoptosisBreast NeoplasmsCell ProliferationCell SurvivalCollagenFemaleGene Expression Regulation, NeoplasticHumansMCF-7 CellsOxidative PhosphorylationPPAR gammaProlineProline OxidaseReactive Oxygen SpeciesAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsCollagenPPAR gammaPRODH protein, humanProlineProline OxidaseReactive Oxygen Speciesapoptosisbreast cancerCOXNSAIDSoxidative stressPPARprolineproline dehydrogenaseproline oxidase

Identifiers

PMID35163433
PMCPMC8835909
OpenAlexW4210303832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.